Arcutis Biotherapeutics
ARQT
ARQT
63 hedge funds and large institutions have $1.02B invested in Arcutis Biotherapeutics in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% less capital invested
Capital invested by funds: $1.02B → $1.02B (-$3.69M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
63
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$14.4M | |
| 2 | +$14.1M | |
| 3 | +$2.8M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.31M |
Top Sellers
| 1 | -$5.44M | |
| 2 | -$5.16M | |
| 3 | -$2.93M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.21M |
| 5 |
Renaissance Technologies
New York
|
-$838K |